Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Dec 2;12:780594. doi: 10.3389/fimmu.2021.780594

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2021 Beilhack, Monteforte, Frommlet, Gaggl, Strassl and Vychytil

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Antibody titers in 39 peritoneal dialysis patients after the first and the second dose of the mRNA-1273 vaccine. Seropositivity was detected in 38 of 39 peritoneal dialysis patients (circles). Antibody titers increased significantly from a median of 6.62 U/mL (IQR 1.57-22.5) four weeks after the first dose to 968 U/mL (IQR 422.5-2500 U/mL) after the second dose (Wilcoxon matched pairs signed rank test, p = 8.057 x 10^-08). The technical upper limit of antibody detection was at 2500 U/mL and was reached in 11 patients (circles may overlap).